Rankings
▼
Calendar
CAMP Q2 2021 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$125M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$80M
-0.7% YoY
Gross Profit
$32M
40.7% margin
Operating Income
-$1M
-1.5% margin
Net Income
-$2M
-2.4% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
-2.8%
Cash Flow
Operating Cash Flow
$78,000
Free Cash Flow
-$3M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$421M
Total Liabilities
$325M
Stockholders' Equity
$96M
Cash & Equivalents
$96M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$80M
$80M
-0.7%
Gross Profit
$32M
$31M
+4.5%
Operating Income
-$1M
-$10M
+87.6%
Net Income
-$2M
-$14M
+86.5%
Revenue Segments
Product
$52M
65%
Application Subscriptions And Other Services
$28M
35%
Geographic Segments
UNITED STATES
$51M
64%
E M E A
$14M
18%
South America
$7M
8%
Asia Pacific
$5M
7%
All Other
$2M
3%
← FY 2021
All Quarters
Q3 2021 →